BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17418878)

  • 1. The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.
    Yan M; Kuang X; Scofield VL; Shen J; Lynn WS; Wong PK
    Steroids; 2007 May; 72(5):415-21. PubMed ID: 17418878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state.
    Yan M; Zhu C; Liu N; Jiang Y; Scofield VL; Riggs PK; Qiang W; Lynn WS; Wong PK
    Free Radic Biol Med; 2006 Aug; 41(4):640-8. PubMed ID: 16863997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Atm-/- thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone.
    Kuang X; Yan M; Liu N; Scofield VL; Qiang W; Cahill J; Lynn WS; Wong PK
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):203-12. PubMed ID: 15570424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thymic lymphoma development in Atm-/- mice by dexamethasone.
    Yan M; Kuang X; Qiang W; Shen J; Claypool K; Lynn WS; Wong PK
    Cancer Res; 2002 Sep; 62(18):5153-7. PubMed ID: 12234978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure.
    Boldizsár F; Pálinkás L; Czömpöly T; Bartis D; Németh P; Berki T
    Immunobiology; 2006; 211(10):785-96. PubMed ID: 17113916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.
    Maclean KH; Kastan MB; Cleveland JL
    Mol Cancer Res; 2007 Jul; 5(7):705-11. PubMed ID: 17634425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4+8+ thymic lymphoma cells.
    Zilberman Y; Zafrir E; Ovadia H; Yefenof E; Guy R; Sionov RV
    Cell Immunol; 2004 Jan; 227(1):12-23. PubMed ID: 15051511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress and unfolded protein response in Atm-deficient thymocytes and thymic lymphoma cells are attributable to oxidative stress.
    Yan M; Shen J; Person MD; Kuang X; Lynn WS; Atlas D; Wong PK
    Neoplasia; 2008 Feb; 10(2):160-7. PubMed ID: 18283338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa.
    Lu YS; Yeh PY; Chuang SE; Gao M; Kuo ML; Cheng AL
    J Endocrinol; 2006 Feb; 188(2):311-9. PubMed ID: 16461557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
    Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
    J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of mTOR signaling is involved in thymic lymphoma development in Atm-/- mice.
    Kuang X; Shen J; Wong PK; Yan M
    Biochem Biophys Res Commun; 2009 Jun; 383(3):368-72. PubMed ID: 19364503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice.
    Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M
    Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of radiation-induced protein kinase Cdelta activation in radiation-induced apoptosis differs between radiosensitive and radioresistant mouse thymic lymphoma cell lines.
    Nakajima T; Yukawa O; Tsuji H; Ohyama H; Wang B; Tatsumi K; Hayata I; Hama-Inaba H
    Mutat Res; 2006 Mar; 595(1-2):29-36. PubMed ID: 16337250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptors take part in the apoptotic process of human lens epithelial cells, but the glucocorticoid receptor antagonist RU486 does not rescue the cells fully.
    Wang L; Zhao W; Leng F; Ge J; Bu Z; Zhang Y; Liu P
    Mol Biosyst; 2011 Jun; 7(6):1926-37. PubMed ID: 21451860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes.
    Wang W; Wykrzykowska J; Johnson T; Sen R; Sen J
    J Immunol; 1999 Jan; 162(1):314-22. PubMed ID: 9886401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired hepatocyte survival and liver regeneration in Atm-deficient mice.
    Lu S; Shen KC; Wang Y; Brooks SC; Wang YA
    Hum Mol Genet; 2005 Oct; 14(20):3019-25. PubMed ID: 16141284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of murine osteosarcoma cell proliferation by glucocorticoid.
    Yamamoto T; Nishiguchi M; Inoue N; Goto HG; Kudawara I; Ueda T; Yoshikawa H; Tanigaki Y; Nishizawa Y
    Anticancer Res; 2002; 22(6C):4151-6. PubMed ID: 12553047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.